SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-21-057536
Filing Date
2021-11-09
Accepted
2021-11-09 08:34:53
Documents
7
Effectiveness Date
2021-11-09

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea150009-s8_enzobio.htm S-8 45702
2 LEGAL OPINION OF MCDERMOTT WILL & EMERY LLP ea150009ex5-1_enzobio.htm EX-5.1 7115
3 CONSENT OF EISNERAMPER LLP. ea150009ex23-1_enzobio.htm EX-23.1 2095
4 INDUCEMENT SIGN-ON RESTRICTED STOCK UNIT GRANT NOTICE AND AGREEMENT ea150009ex99-1_enzobio.htm EX-99.1 49631
5 INDUCEMENT SIGN-ON OPTION GRANT NOTICE AND AGREEMENT ea150009ex99-2_enzobio.htm EX-99.2 50623
6 GRAPHIC ex5-1_001.jpg GRAPHIC 10596
7 GRAPHIC ex5-1_002.jpg GRAPHIC 8118
  Complete submission text file 0001213900-21-057536.txt   182195
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: S-8 | Act: 33 | File No.: 333-260894 | Film No.: 211390021
SIC: 8071 Services-Medical Laboratories